{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T07:30:20Z","timestamp":1772782220183,"version":"3.50.1"},"reference-count":136,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":5302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1046\/j.1523-1755.2001.00716.x","type":"journal-article","created":{"date-parts":[[2004,12,27]],"date-time":"2004-12-27T17:32:30Z","timestamp":1104168750000},"page":"2005-2022","source":"Crossref","is-referenced-by-count":33,"title":["Treatment prospects for autosomal-dominant polycystic kidney disease"],"prefix":"10.1016","volume":"59","author":[{"given":"Qi","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0010","first-page":"327","article-title":"Molecular basis of autosomal dominant polycystic kidney disease","volume":"19","author":"Watnick","year":"1999","journal-title":"Semin Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0015","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00041552-200007000-00010","article-title":"The pathogenesis of autosomal dominant polycystic kidney disease: An update","volume":"9","author":"Somlo","year":"2000","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0020","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1046\/j.1523-1755.1999.00370.x","article-title":"New insights into the molecular pathophysiology of polycystic kidney disease","volume":"55","author":"Murcia","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00041552-199803000-00004","article-title":"New insights into polycystic kidney disease and its treatment","volume":"7","author":"Torres","year":"1998","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0030","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: Neoplasia in disguise","volume":"15","author":"Grantham","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0035","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-230X(08)61026-X","article-title":"Perspectives on cancer chemoprevention research and drug development","volume":"78","author":"Kelloff","year":"2000","journal-title":"Adv Cancer Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0040","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1086\/302501","article-title":"A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2","volume":"65","author":"Torra","year":"1999","journal-title":"Am J Hum Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0045","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","article-title":"Somatic PKD2 mutations in individual kidney and liver cysts support a \u201ctwo-hit\u201d model of cystogenesis in type 2 autosomal dominant polycystic kidney disease","volume":"10","author":"Pei","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0050","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/hmg\/8.3.509","article-title":"Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease","volume":"8","author":"Koptides","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0055","article-title":"Mutation analysis of the entire PKD1 gene: Genetic and diagnostic implications","author":"Rossetti","year":"1958","journal-title":"Genetic and diagnostic implicationss"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/mgme.1999.2943","article-title":"Molecular genetics and mechanism of autosomal dominant polycystic kidney disease","volume":"69","author":"Wu","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0065","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/5944","article-title":"Late onset of renal and hepatic cysts in mice heterozygous for a targeted PKD1 mutation","volume":"21","author":"Lu","year":"1999","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0070","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1073\/pnas.040550097","article-title":"Polycystin 1 is required for the structural integrity of blood vessels","volume":"97","author":"Kim","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0075","first-page":"317","article-title":"A 2.5kb polypyrimidine tract in the PKD1 gene contains at least 23 H-DNA-forming sequences","volume":"1","author":"Van Raay","year":"1996","journal-title":"Microb Comp Genomics"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0080","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/hmg\/7.8.1239","article-title":"Gene conversion is a likely cause of mutation in PKD1","volume":"7","author":"Watnick","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0085","doi-asserted-by":"crossref","first-page":"9102","DOI":"10.1073\/pnas.94.17.9102","article-title":"Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice","volume":"94","author":"Gnarra","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0090","first-page":"1206","article-title":"Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice","volume":"59","author":"Kobayashi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/hmg\/5.2.215","article-title":"Somatic mutations are frequent and increase with age in human kidney epithelial cells","volume":"5","author":"Martin","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0100","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1046\/j.1523-1755.1999.00659.x","article-title":"Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2\/PKD1 cystic tissue","volume":"56","author":"Ong","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1056\/NEJM199507063330104","article-title":"Apoptosis and loss of renal tissue in polycystic kidney diseases","volume":"333","author":"Woo","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0110","first-page":"1153","article-title":"Dysregulation of cellular proliferation and apoptosis mediates human autosomal dominant polycystic kidney disease (ADPKD)","volume":"13","author":"Lanoix","year":"1996","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0115","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1523-1755.2001.00473.x","article-title":"The pck rat, a new model that resembles human autosomal dominant polycystic kidney and liver disease","volume":"59","author":"Lager","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0120","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V17980","article-title":"A hereditary model of slowly progressive polycystic kidney disease in the mouse","volume":"1","author":"Takahashi","year":"1991","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0125","first-page":"386","article-title":"Renal cysts in transgenic mice expressing transforming growth factor-alpha","volume":"124","author":"Lowden","year":"1994","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1083\/jcb.122.1.199","article-title":"An activated allele of the c-erbB-2 oncogene impairs kidney and lung function and causes early death of transgenic mice","volume":"122","author":"Stocklin","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0135","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ki.1991.80","article-title":"c-myc as an inducer of polycystic kidney disease in transgenic mice","volume":"39","author":"Trudel","year":"1991","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0140","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1093\/hmg\/9.18.2617","article-title":"A human PKD1 transgene generates functional polycystin-1 in mice and is associated with a cystic phenotype","volume":"9","author":"Pritchard","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0145","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/hmg\/9.3.447","article-title":"Genetic evidence or a trans-heterozygous model for cystogenesis in autosomal dominant polycystic kidney disease","volume":"9","author":"Koptides","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/75981","article-title":"Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of transheterozygous mutations","volume":"25","author":"Watnick","year":"2000","journal-title":"Nat Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0155","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/ki.1996.433","article-title":"Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type Tg737 cDNA","volume":"50","author":"Yoder","year":"1996","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0160","first-page":"1311","article-title":"The PKD1 gene product, \u201cPolycystin-1,\u201d is a tyrosine-phosphorylated protein that colocalizes with alpha 2 beta 1-integrin in focal clusters in adherent renal epithelia","volume":"79","author":"Wilson","year":"1999","journal-title":"Lab Invest"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0165","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI5111","article-title":"Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins","volume":"104","author":"Huan","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0170","doi-asserted-by":"crossref","first-page":"28557","DOI":"10.1074\/jbc.274.40.28557","article-title":"Identification and characterization of polycystin-2, the PKD2 gene product","volume":"274","author":"Cai","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0175","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3390481","article-title":"Extracellular matrix and integrin signalling: The shape of things to come","volume":"339","author":"Boudreau","year":"1999","journal-title":"Biochem J"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0180","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0955-0674(99)00021-6","article-title":"Mechanism of cell-cell adhesion complex assembly","volume":"11","author":"Troyanovsky","year":"1999","journal-title":"Curr Opin Cell Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0185","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/bbrc.1999.1860","article-title":"Regulation of beta-catenin signaling in the Wnt pathway","volume":"268","author":"Kikuchi","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0190","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/(SICI)1521-1878(199912)22:1<1021::AID-BIES6>3.0.CO;2-P","article-title":"Beta-catenin signaling and cancer","volume":"21","author":"Morin","year":"1999","journal-title":"Bioessays"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0195","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s004670050275","article-title":"Distribution of alpha-integrin subunits in fetal polycystic kidney diseases","volume":"11","author":"Daikha-Dahmane","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0200","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1083\/jcb.136.6.1349","article-title":"Progressive kidney degeneration in mice lacking tensin","volume":"136","author":"Lo","year":"1997","journal-title":"J Cell Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0205","first-page":"F679","article-title":"Attenuated expression of epithelial cell adhesion molecules in murine polycystic kidney disease","volume":"262","author":"Rocco","year":"1992","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0210","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1074\/jbc.274.8.4947","article-title":"The polycystic kidney disease 1 gene product modulates Wnt signaling","volume":"274","author":"Kim","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0215","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1083\/jcb.149.1.111","article-title":"Compromised cytoarchitecture and polarized trafficking in autosomal dominant polycystic kidney disease cells","volume":"149","author":"Charron","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0220","first-page":"F758","article-title":"Mouse proximal tubular cell-cell adhesion inhibits apoptosis by a cadherin-dependent mechanism","volume":"278","author":"Bergin","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0225","first-page":"3875","article-title":"Intestinal dysplasia and adenoma in transgenic mice after overexpression of an activated beta-catenin","volume":"59","author":"Romagnolo","year":"1999","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0230","first-page":"2513","article-title":"Progression of autosomal dominant polycystic kidney disease (ADPKD) to renal failure,","volume":"vol 2","author":"Grantham","year":"2000","journal-title":"The Kidney: Physiology and Pathophysiology Philadelphia, Lippincott Williams & Wilkins"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0235","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1681\/ASN.V102218","article-title":"ATP release mechanisms in primary cultures of epithelia derived from the cysts of polycystic kidneys","volume":"10","author":"Wilson","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0240","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/ki.1996.387","article-title":"Role of obstruction in autosomal dominant polycystic kidney disease in rats","volume":"50","author":"Tanner","year":"1996","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0245","article-title":"Renal expression of CYP1A1 and CYP1B1 in polycystic kidneys of HAN:SPRD rats","author":"Bhattacharyya","year":"1896","journal-title":"Renal expression of CYP1A1 and CYP1B1 in polycystic kidneys of HAN:SPRD rat"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0250","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0027-5107(95)00096-8","article-title":"Antioxidant defenses against reactive oxygen species causing genetic and other damage","volume":"350","author":"Anderson","year":"1996","journal-title":"Mutat Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0255","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.V881283","article-title":"Aggravation of polycystic kidney disease in HAN:SPRD rats by buthionine sulfoximine","volume":"8","author":"Torres","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0260","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0272-6386(00)70330-1","article-title":"Effect of probucol in a murine model of slowly progressive polycystic kidney disease","volume":"35","author":"Nagao","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0265","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1053\/ajkd.1998.v31.pm9531187","article-title":"Renal concentration of alpha-tocopherol: Dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats","volume":"31","author":"Torres","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0270","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1681\/ASN.V561355","article-title":"Early dietary protein restriction slows disease progression and lengthens survival in mice with polycystic kidney disease","volume":"5","author":"Tomobe","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0275","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1681\/ASN.V661649","article-title":"Amelioration of polycystic kidney disease by modification of dietary protein intake in the rat","volume":"6","author":"Ogborn","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)80097-7","article-title":"Reduction of remnant nephron hypermetabolism by protein restriction","volume":"18","author":"Jarusiripipat","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/ajkd.1998.v31.pm9428452","article-title":"Effect of dietary soy protein and genistein on disease progression in mice with polycystic kidney disease","volume":"1","author":"Tomobe","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0290","first-page":"F541","article-title":"Soy protein modification of rat polycystic kidney disease","volume":"274","author":"Ogborn","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0295","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1523-1755.2000.00835.x","article-title":"Modification of polycystic kidney disease and fatty acid status by soy protein diet","volume":"57","author":"Ogborn","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0300","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0272-6386(00)70265-4","article-title":"Gender dependent effect of L-NAME on polycystic kidney disease in HAN. SPRD rats","volume":"35","author":"Yoshida","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0305","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0163-7258(99)00026-1","article-title":"Omega-3 fatty acids as cancer chemopreventive agents","volume":"83","author":"Rose","year":"1999","journal-title":"Pharmacol Ther"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0310","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1523-1755.2001.00465.x","article-title":"Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats","volume":"59","author":"Aukema","year":"2001","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0315","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1755.1999.00287.x","article-title":"Flaxseed ameliorates interstitial nephritis in rat polycystic kidney disease","volume":"55","author":"Ogborn","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0320","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0271-5317(05)80537-8","article-title":"Effects of dietary fish oil on survival and renal fatty acid composition in murine polycystic kidney disease","volume":"12","author":"Aukema","year":"1992","journal-title":"Nutr Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0325","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.V551193","article-title":"Renal cystic disease and ammoniagenesis in Han:SPRD rats","volume":"5","author":"Torres","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0330","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V971242","article-title":"Potassium citrate\/citric acid intake improves renal function in rats with polycystic kidney disease","volume":"9","author":"Tanner","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0335","article-title":"Long-term ammonium chloride or sodium bicarbonate treatment in two models of polycystic kidney disease","author":"Torres","year":"1859","journal-title":"Exp Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0340","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000045588","article-title":"Effects of potassium citrate\/citric acid intake in a mouse model of polycystic kidney disease","volume":"84","author":"Tanner","year":"2000","journal-title":"Nephron"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0345","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-230X(08)60784-8","article-title":"Biochemical and clinical implications of the erbB\/HER signaling network of growth factor receptors","volume":"77","author":"Klapper","year":"2000","journal-title":"Adv Cancer Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0350","doi-asserted-by":"crossref","first-page":"6666","DOI":"10.1128\/MCB.18.11.6666","article-title":"Integration of growth factor, extracellular matrix, and retinoid signals during bronchial epithelial cell differentiation","volume":"18","author":"Moghal","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0355","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0012-1606(90)90192-L","article-title":"Defective epidermal growth factor gene expression in mice with polycystic kidney disease","volume":"138","author":"Gattone","year":"1990","journal-title":"Dev Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0360","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1681\/ASN.V661679","article-title":"Abnormal expression of epidermal growth factor and sulfated glycoprotein SGP-2 messenger RNA in a rat model of autosomal dominant polycystic kidney disease","volume":"6","author":"Cowley","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0365","first-page":"131","article-title":"Autocrine, endocrine,and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease","volume":"61","author":"Wilson","year":"1993","journal-title":"Eur J Cell Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0370","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0022-5347(01)64084-9","article-title":"Expression of transforming growth factor alpha and epidermal growth factor receptor in adult polycystic kidney disease","volume":"159","author":"Lee","year":"1998","journal-title":"J Urol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0375","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.1995.269.2.C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0380","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1523-1755.2000.00829.x","article-title":"Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor","volume":"57","author":"Sweeney","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0385","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/ki.1991.239","article-title":"C-erb B-2 amplification in cystic renal disease","volume":"40","author":"Herrera","year":"1991","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0390","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S0022-2143(96)90081-5","article-title":"Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse","volume":"127","author":"Gattone","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0395","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/BF00862522","article-title":"Polypeptide growth factors in metanephric growth and segmental nephron differentiation","volume":"4","author":"Avner","year":"1990","journal-title":"Pediatr Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0400","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/ki.1992.184","article-title":"In vitro formation and expansion of cysts derived from human renal cortex epithelial cells","volume":"41","author":"Neufeld","year":"1992","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0405","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/ki.1995.118","article-title":"Tyrosine kinase activity of the EGF receptor in murine metanephric organ culture","volume":"47","author":"Pugh","year":"1995","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0410","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1523-1755.1999.00577.x","article-title":"In vitro modulation of cyst formation by a novel tyrosine kinase inhibitor","volume":"56","author":"Sweeney","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0415","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0420","first-page":"3","article-title":"Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer","volume":"15","author":"Fry","year":"2000","journal-title":"Anticancer Drug Des"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0425","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2165\/00003495-200059040-00003","article-title":"Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily","volume":"59","author":"Noonberg","year":"2000","journal-title":"Drugs"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0430","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/sj.onc.1202174","article-title":"Increasing complexity of Ras signaling","volume":"17","author":"Campbell","year":"1998","journal-title":"Oncogene"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0435","first-page":"1051","article-title":"Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys","volume":"142","author":"Schaffner","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0440","first-page":"C19","article-title":"Farnesyltransferase inhibitors: Targeting the molecular basis of cancer","volume":"1423","author":"Oliff","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0445","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1040-8428(99)00053-0","article-title":"Inhibition of RAS-targeted prenylation: Protein farnesyl transferase inhibitors revisited","volume":"33","author":"Hill","year":"2000","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0450","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0272-6386(95)90497-2","article-title":"Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat","volume":"26","author":"Gile","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0455","first-page":"1843","article-title":"Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts","volume":"3","author":"Grantham","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0460","first-page":"439","article-title":"Ion transport and cystogenesis: The paradigm of autosomal dominant polycystic kidney disease","volume":"28","author":"Devuyst","year":"1998","journal-title":"Adv Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0465","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1046\/j.1523-1755.2000.00991.x","article-title":"cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway","volume":"57","author":"Yamaguchi","year":"2000","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0470","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","article-title":"cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells","volume":"11","author":"Hanaoka","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0475","first-page":"821","article-title":"Interactions between the epidermal growth factor receptor and type I protein kinase A: Biological significance and therapeutic implications","volume":"4","author":"Ciardiello","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0480","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jnci\/90.14.1087","article-title":"Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide","volume":"90","author":"Ciardiello","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0485","first-page":"D898","article-title":"Antisense DNA-targeting protein kinase A-RIA subunit: A novel approach to cancer treatment","volume":"4","author":"Cho-Chung","year":"1999","journal-title":"Front Biosci"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0490","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1172\/JCI9084","article-title":"Anticancer drug targets: Growth factors and growth factor signaling","volume":"105","author":"Gibbs","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0014-4800(92)90047-F","article-title":"In vivo formation of polyphosphoinositide isomers and association with progression of murine polycystic kidney disease","volume":"57","author":"Aukema","year":"1992","journal-title":"Exp Mol Pathol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0500","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1023\/A:1006328303451","article-title":"Protein kinase C targeting in antineoplastic treatment strategies","volume":"17","author":"Jarvis","year":"1999","journal-title":"Invest New Drugs"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0505","doi-asserted-by":"crossref","first-page":"19925","DOI":"10.1074\/jbc.273.32.19925","article-title":"Increasing complexity of the Ras signaling pathway","volume":"273","author":"Vojtek","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0510","series-title":"Polycystic Kidney Disease","first-page":"125","article-title":"Pathogenesis of polycystic kidney disease: Altered cellular function,","author":"Wilson","year":"1996"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0515","first-page":"4208","article-title":"Activation of the P13\u2032K-AKT pathway masks the proapoptotic effects of farnesyltransferase inhibitors","volume":"59","author":"Du","year":"1999","journal-title":"Cancer Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0520","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-2275(20)41159-9","article-title":"Abnormalities of glycosphingolipid sulfatide, and ceramide in the polycystic (cpk\/cpk) mouse","volume":"35","author":"Deshmukh","year":"1994","journal-title":"J Lipid Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0525","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","article-title":"Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease","volume":"37","author":"Chatterjee","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0530","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0005-2760(91)90130-A","article-title":"Rapid kidney changes resulting from glycosphingolipid depletion by treatment with a glucosyltransferase inhibitor","volume":"1083","author":"Shukla","year":"1991","journal-title":"Biochim Biophys Acta"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0535","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00001622-199911000-00011","article-title":"The biologic basis for the use of retinoids in cancer prevention and treatment","volume":"11","author":"Kurie","year":"1999","journal-title":"Curr Opin Oncol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0540","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00001622-199809000-00019","article-title":"Retinoids in the chemoprevention of bladder cancer","volume":"10","author":"Sabichi","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0545","doi-asserted-by":"crossref","first-page":"PL259","DOI":"10.1016\/S0024-3205(99)00155-1","article-title":"N-(4-hydroxyphenyl) retinamide inhibits cystogenesis by polycystic epithelial cell line in vitro","volume":"64","author":"Altierei","year":"1999","journal-title":"Life Sci"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0550","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00041552-199807000-00008","article-title":"Recent developments in the use of vitamin D analogues","volume":"7","author":"Verstuyf","year":"1998","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0555","first-page":"R763","article-title":"Apoptosis in polycystic kidney disease: Involvement of caspases","volume":"278","author":"Ali","year":"2000","journal-title":"Am J Physiol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0560","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1006\/dbio.2000.9618","article-title":"Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease","volume":"219","author":"Ostom","year":"2000","journal-title":"Dev Biol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0565","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1172\/JCI9053","article-title":"Apoptosis and cancer drug targeting","volume":"104","author":"Sellers","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0570","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1161\/01.RES.86.4.371","article-title":"Toward antiapoptosis as a new treatment modality","volume":"86","author":"Haunsteter","year":"2000","journal-title":"Circ Res"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0575","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1038\/ki.1997.222","article-title":"Microtubule active taxanes inhibit polycystic kidney disease progression in cpk mice","volume":"51","author":"Woo","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0580","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/bbrc.1999.1375","article-title":"The mode of action of taxol: Apoptosis at low concentration and necrosis at high concentration","volume":"263","author":"Yeung","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0585","first-page":"1215","article-title":"Possible mechanisms of paclitaxel-induced apoptosis","volume":"57","author":"Fan","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0590","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0272-6386(97)90206-7","article-title":"The effect of paclitaxel on the progression of polycystic kidney disease in rodents","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0595","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1007\/s004670050376","article-title":"Efficacy of taxol in the orpk mouse model of polycystic kidney disease","volume":"11","author":"Sommardahl","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0600","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0272-6386(98)70072-1","article-title":"Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease","volume":"32","author":"O'Sullivan","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0605","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/hep.1840110406","article-title":"Functional similarities of hepatic cystic and biliary epithelium: Studies of fluid constituents and in vivo secretion in response to secretin","volume":"11","author":"Everson","year":"1990","journal-title":"Hepatology"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0610","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1038\/ki.1997.211","article-title":"Effects of sex hormones on fluid and solute transport Madin-Darby canine kidney cells","volume":"51","author":"Sandhu","year":"1997","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0615","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/(SICI)1520-6408(1999)24:3\/4<309::AID-DVG14>3.0.CO;2-5","article-title":"Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease","volume":"24","author":"Gattone","year":"1999","journal-title":"Dev Genet"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0620","first-page":"265","article-title":"Extrarenal manifestations in autosomal dominant polycystic kidney disease","volume":"26","author":"Chauveau","year":"1997","journal-title":"Adv Nephrol Necker Hosp"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0625","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1021\/jm990377j","article-title":"New \u03b1-substituted succinate-based hydroxamic acids as TNF\u03b1 convertase inhibitors","volume":"42","author":"Barlaam","year":"1999","journal-title":"J Med Chem"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0630","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1021\/jm980541n","article-title":"Therapeutic potential and strategies for inhibiting tumor necrosis factor-\u03b1","volume":"13","author":"Newton","year":"1999","journal-title":"J Med Chem"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0635","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0272-6386(95)90013-6","article-title":"Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents","volume":"25","author":"Gattone","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0640","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1023\/A:1006386406584","article-title":"Matrix metalloproteinase inhibitors: Applications in oncology","volume":"17","author":"Yip","year":"1999","journal-title":"Invest New Drugs"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0645","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000013552","article-title":"Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease","volume":"20","author":"Nakamura","year":"2000","journal-title":"Am J Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0650","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0272-6386(12)80907-3","article-title":"Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats","volume":"24","author":"Keith","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0655","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/0272-6386(95)90059-4","article-title":"Cilazapril delays progression of hypertension and uremia in rat polycystic kidney disease","volume":"26","author":"Ogborn","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0660","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1046\/j.1523-1755.1999.00783.x","article-title":"Hypertension and renal injury in experimental polycystic kidney disease","volume":"56","author":"Kennefick","year":"1999","journal-title":"Kidney Int"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0665","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0272-6386(12)80212-5","article-title":"Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: Possible evidence of heterogeneity in cystogenesis","volume":"24","author":"Munemura","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0670","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000424407","article-title":"Plasma concentration of endothelin and arterial pressure in patients with ADPKD","volume":"115","author":"Giusti","year":"1995","journal-title":"Contrib Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0675","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1681\/ASN.V441064","article-title":"Increased endothelin and endothelin receptor mRNA expression in polycystic kidneys of cpk mice","volume":"4","author":"Nakamura","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0680","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1172\/JCI119297","article-title":"Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension","volume":"99","author":"Hocher","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1046\/j.1523-1755.2001.00716.x_bb0685","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V971169","article-title":"Renal endothelin system in polycystic kidney disease","volume":"9","author":"Hocher","year":"1998","journal-title":"J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815476951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815476951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T21:26:54Z","timestamp":1635542814000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815476951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":136,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S0085253815476951"],"URL":"https:\/\/doi.org\/10.1046\/j.1523-1755.2001.00716.x","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}